Concord Biotech commences production of injectable at Valthera facility

25 Mar 2025 Evaluate

Concord Biotech has successfully commissioned and commenced production of injectable at its new manufacturing facility situated at Valthera. This advanced facility has been designed and constructed to adhere to stringent international standards, equipped with cutting-edge technology to ensure the consistent delivery of high-quality products. The operationalization of Unit-4 is a part of company's strategic growth initiatives.

Concord Biotech is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology. 


Concord Biotech Share Price

1404.05 1.00 (0.07%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×